ArticleFrontiers in pharmacology2025

Rifapentine- and moxifloxacin-containing short-course regimens for mild spinal tuberculosis: study protocol for a multicenter, randomized, non-inferiority phase II clinical trial.

Yue-E Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.